Supplemental Clinical Criteria: Psychological and Neuropsychological Testing
Customize your policy alerts
Sign up for Optum Policy BH803PNTSCC0102025 alerts
Get alerted when Policy BH803PNTSCC0102025 changes without checking for updates manually.
Monitor payer policy activity
Supplemental clinical criteria governing provider qualifications, coverage rationale, limitations, and developmental/automated testing guidance for psychological and neuropsychological testing for behavioral health benefit plans managed by Optum; applies to reviewers and providers when determining coverage and prior authorization. Does not apply to Department of Managed Health Care-regulated Commercial Health Plans in California.
No material clinical or coverage changes in this revision.
Coverage Criteria — When Testing Is (Not) Covered
inv-01: Not medically necessary — specified uses
Neuropsychological testing is considered unproven and not medically necessary for the following specific uses:
These uses are explicitly listed as unproven and not medically necessary in the policy.
inv-02: Tele-assessment coverage criteria
Tele-assessment coverage and exceptions
Consult member-specific benefit plan documents and applicable mandates.
Examples include geographic isolation or lack of available qualified providers.
All listed safeguards and competency requirements must be satisfied for coverage.
inv-03: Non-behavioral benefit testing
Services not typically covered under the behavioral health benefit
Codes and descriptions are listed in the policy as typically not covered under behavioral health.
This Supplemental Clinical Criteria does not apply to Department of Managed Health Care–regulated commercial health plans in California. Reviewers and providers must therefore follow any superseding California-specific rules and the member's specific benefit plan when making coverage and authorization determinations for those plans.
Face-to-face assessment is the standard of care for psychological and neuropsychological testing. Tele-assessment is typically not covered unless required by regulation or contract and only when case-specific criteria are met (for example, to reach isolated populations or when no qualified local providers are available).
Tele-assessment may be considered only if all required conditions are satisfied: the provider is licensed/credentialed in the member's state and proficient in telehealth delivery; a HIPAA-compliant telehealth platform is used; test materials are secured; adequate audio-visual monitoring of test administration will occur; the member is an appropriate candidate with access to and literacy for the required technology; informed consent for telehealth testing has been obtained; and the selected tests can be administered remotely without undermining validity or reliability.
Computerized or automated neuropsychological tests have limited applications within this coverage guideline. Specifically, computerized neuropsychological testing when used alone for evaluating concussions is considered unproven and not medically necessary. Certain commercial products (for example, Mindstreams® Cognitive Health Assessment and QbTest) are explicitly listed as not medically necessary when used in isolation.
Evidence summarized in the document indicates variable validity and limited impact on long-term clinical outcomes for computerized cognitive testing; some studies of continuous performance tests (e.g., QbTest) show limited ability to distinguish ADHD from other psychiatric conditions, underscoring the limitation of relying on computerized tests alone for diagnostic decisions.
Tele-assessment is not medically necessary when remote delivery would require modifications that undermine test validity, reliability, security, or adequate monitoring. Examples include situations where standard administration procedures must be modified to such an extent that test score reliability or validity is compromised, or where essential tests cannot be administered remotely.
Tele-assessment is also not appropriate when member or provider circumstances prevent reliable remote administration: the provider is not licensed or credentialed in the member's state, is not sufficiently proficient in telehealth, a HIPAA-compliant platform will not be used, test materials cannot be secured, adequate audio-visual monitoring is not possible, the member lacks technology access or literacy, the member is not a suitable candidate due to age/condition/environment, or informed consent for telehealth testing has not been obtained.
Coding — CPT and Related Codes
Provider Actions, Prior Authorization, and Documentation
Prior authorization: verify eligibility, benefits, and regulatory requirements
Confirm member eligibility, member-specific benefit coverage, and any federal/state regulatory requirements that supersede the member's benefits prior to authorization. Have provider qualification documentation and rationale for selected tests available to support prior authorization decisions.
- Verify member eligibility and the member-specific benefit plan before applying these criteria.
- Identify and follow any superseding federal or state mandates that override member benefits.
- Make provider licensure/training documentation and test selection rationale available to the reviewer.
Tele-assessment prior authorization: consult member plan and mandates
Tele-assessment is generally not authorized unless required by regulation or contract; consult the member-specific benefit plan and applicable mandates to determine whether remote testing may be authorized.
- Check member-specific benefit plan documents and any federal/state mandates before authorizing tele-assessment.
- Recognize that face-to-face assessment is the standard of care; exceptions are case-by-case (e.g., provider shortages, geographic isolation).
Include referral rationale, test selection, and provider qualifications with requests
Provide documentation to support any request: include the clinical referral question, test selection rationale, and evidence of provider qualifications specific to the requested tests.
- Include the clinical reason for testing and why selected instruments are necessary to answer the referral question.
- Attach documentation of provider training/licensure appropriate to the test type.
Triage: use brief screening (96127) for detection/monitoring, not definitive diagnosis
Use brief screening (96127) for detection, monitoring, or to inform referrals; do not use 96127 as a definitive diagnostic test — it should not substitute for comprehensive psychological or neuropsychological testing.
- 96127 may inform the decision to refer for formal testing but is not considered definitive diagnostic testing.
- Brief screening services are typically managed under medical benefits, not behavioral health, unless contractually required.
Document provider qualifications and supervision for testing
Document provider licensure, training, and supervision consistent with the test type: doctoral-level psychologists or appropriately credentialed psychiatrists for neuropsychological testing; psychometrists must be supervised with the supervising psychologist providing intake and feedback, final interpretation, report writing, and signature.
- Doctoral-level psychologists must be licensed to practice independently and demonstrate sufficient training/experience.
- Credentialed psychiatrists must meet listed board accreditation, state licensure, and documented expertise for neuropsychological testing.
- Psychometrists administer/score under supervision; supervising psychologist must have face-to-face contact at intake and feedback and is responsible for final interpretation and signature.
Tele-assessment documentation and safeguards: platforms, materials, monitoring, licensure, consent
For tele-assessment, document use of a HIPAA-compliant platform, measures to secure test materials, evidence of audiovisual monitoring, appropriate state licensure/credentialing, and documented informed consent describing risks and limitations.
- Use a HIPAA-compliant telehealth platform and document the platform used.
- Document how test materials will be secured and how audio-visual monitoring of administration will occur.
- Confirm and document that the provider is licensed/credentialed in the state where the member receives testing.
- Obtain and document informed consent that plainly communicates risks and limitations of remote assessment.
Denial triggers: evaluate against member benefits and listed not-medically-necessary uses
Evaluate requests against the member's benefits and any applicable mandates; services that are limited, excluded, or defined differently by the member's benefit may be denied, including certain computerized testing uses explicitly listed as not medically necessary.
- Denials may result when the requested service is limited or excluded by the member's benefit.
- Computerized neuropsychological testing used alone for evaluating concussions and baseline testing in asymptomatic persons at risk for sport-related concussions are listed as not medically necessary and may be denied.
Tele-assessment denial triggers: availability, proficiency, licensure, security, validity, consent
Tele-assessment may be denied when in-person testing is available; when the provider lacks telehealth proficiency or state licensure/credentialing; when a HIPAA-compliant platform, secured materials, or adequate audio-visual monitoring are not used; when the member is not an appropriate candidate or lacks technology access; when tests cannot be administered remotely without undermining validity; or when informed consent for telehealth testing has not been obtained.
- Not covered if in-person testing is available.
- Not covered if provider is not proficient in telehealth or not licensed/credentialed in the member's state.
- Not covered if HIPAA-compliant platform will not be used or test materials cannot be secured.
- Not covered if adequate audiovisual monitoring will not occur or the member lacks access/technology literacy.
- Not covered if required tests cannot be remotely administered or standard procedures would need modification that undermines validity.
- Not covered if informed consent for telehealth testing has not been secured and risks/limitations not communicated.
Key Definitions
Automated / Computerized Testing — Role and Limits
inv-23: Automated/computerized cognitive testing — single top-level node summarizing scope and status
Automated/computerized cognitive testing — scope and summary of policy stance
Summarizes the document's assessment of automated testing utility and limitations.
Background and Evidence Summary
Psychological and neuropsychological testing are formal, structured procedures that use reliable and validated instruments to measure intellectual, cognitive, emotional, and behavioral functioning and to identify brain dysfunction or psychopathology. These services include test selection, review of records, administration/scoring, integration of clinical data, interpretation, report preparation, and feedback to the member or caregiver.
Neuropsychological testing focuses specifically on identifying brain injury, damage, or dysfunction and the associated functional deficits and typically requires specialized test batteries and interpretation by appropriately trained providers.
Automated or computerized testing can serve as a screening tool or to estimate change over time, but its use is limited by variable sensitivity and validity across instruments and contexts. Such tools should not replace full psychological or neuropsychological assessment when definitive diagnostic information is required.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.